Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 32, Issue 3, 2005, Pages 211-217

  Qin, Min ^b   Escuadro, Brian ^b   Sharma, Sherven ^b   Batra, Raj K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

CAR; FGF2; Gene therapy; Lung cancer; Molecular conjugates

Indexed keywords

ADENOVIRUS VECTOR; CD51 ANTIGEN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEOHEPARAN SULFATE; CAR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; VIRUS RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FIBROBLAST; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS;

ADENOVIRIDAE; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IMMUNOGLOBULIN FAB FRAGMENTS; LUNG NEOPLASMS; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS;

EID: 15044356745     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0226OC     Document Type: Article

References (36)

1. Batra R, Olsen J, Pickles R, Hoganson S, Boucher R. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors. Am J Respir Cell Mol Biol 1998;18:402-410.
2. Jain RK. The next frontier of molecular medicine: delivery of therapeutics. Nat Med 1998;4:655-657.
3. Batra RK, Dubinett SM, Henkle BW, Sharma S, Gardner BK. Adenoviral gene transfer is inhibited by soluble factors in malignant pleural effusions. Am J Respir Cell Mol Biol 2000;22:613-619.
4. Pilewski JM. Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency. Am J Respir Cell Mol Biol 2002;27:117-121.
5. Bernal RM, Sharma S, Gardner BK, Douglas JT, Bergelson JM, Dubinett SM, Batra RK. Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin Cancer Res 2002;8:1915-1923.
6. Batra R, Olsen J, Hoganson D, Caterson B, Boucher R. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions. J Biol Chem 1997;18:11736-11743.
7. Qin M, Chen S, Yu T, Escuadro B, Sharma S, Batra RK. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts. Clin Cancer Res 2003;9:4992-4999.
8. Volm M, Koomagi R, Mattern J, Stammler G. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res 1997;17:99-103.
9. Volm M, Koomagi R, Mattern J, Stammler G. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer 1997;33:691-693.
10. Takanami I, Imamuma T, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, Kodaira S. Expression of PDGF, IGF-II, bFGF and TGF-beta 1 in pulmonary adenocarcinoma. Pathol Res Pract 1996;192:1113-1120.
11. Takanami I, Tanaka F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, Kodaira S. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 1996;32A:1504-1509.
12. Yayon A, Klagsbrun M. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc Natl Acad Sci USA 1990;87:5346-5350.
13. Lappi DA. Tumor targeting through fibroblast growth factor receptors. Semin Cancer Biol 1995;6:279-288.
14. Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A, Pierce GF. Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int J Cancer 1999;81: 451-458.
15. Sosnowski BA, Gu DL, D'Andrea M, Doukas J, Pierce GF. FGF2-targeted adenoviral vectors for systemic and local disease. Curr Opin Mol Ther 1999;1:573-579.
16. Rogers B, Douglas J, Ahlem C, Buchsbaum D, Frincke J, Curiel D. Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther 1997;4:1387-1392.
17. Rancourt C, Rogers BE, Sosnowski BA, Wang M, Piche A, Pierce GF, Alvarez RD, Siegal GP, Douglas JT, Curiel DT. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer. Clin Cancer Res 1998;4:2455-2461.
18. Printz MA, Gonzalez AM, Cunningham M, Gu DL, Ong M, Pierce GF, Aukerman SL. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Hum Gene Ther 2000; 11:191-204.
19. Kleeff J, Fukahi K, Lopez ME, Friess H, Buchler MW, Sosnowski BA, Korc M. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors. Cancer Gene Ther 2002;9:522-532.
20. Gu DL, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, et al. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res 1999;59:2608-2614.
21. Goldman C, Rogers B, Douglas J, Sosnowski B, Ying W, Siegal G, Baird A, Campain J, Curiel D. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res 1997;57: 1447-1451.
22. Sosnowski BA, Gonzalez AM, Chandler LA, Buechler YJ, Pierce GF, Baird A. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J Biol Chem 1996;271:33647-33653.
23. Doukas J, Hoganson DK, Ong M, Ying W, Lacey DL, Baird A, Pierce GF, Sosnowski BA. Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways. FASEB J 1999;13:1459-1466.
24. Hoganson DK, Sosnowski BA, Pierce GF, Doukas J. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand. Mol Ther 2001;3:105-112.
25. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2:Reviews 3005:1-12.
26. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 1988;62:1647-1652.
27. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996;70: 7498-7509.
28. Lappi DA, Matsunami R, Martineau D, Baird A. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin. Anal Biochem 1993;212:446-451.
29. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996;14:1574-1578.
30. Odrljin TM, Haidaris CG, Lerner NB, Simpson-Haidaris PJ. Integrin αvβ3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells. Am J Respir Cell Mol Biol 2001;24:12-21.
31. Sharma S, Stolina M, Zhu L, Lin Y, Batra R, Huang M, Strieter R, Dubinett SM. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res 2001;61:6406-6412.
32. Varghese R, Mikyas Y, Stewart PL, Ralston R. Postentry neutralization of adenovirus type 5 by an antihexon antibody. J Virol 2004;78:12320-12332.
33. Batra R, Wang-Johanning F, Wagner E, Garver RJ, Curiel D. Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther 1994;1:255-260.
34. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997;18:26-45.
35. Davison E, Kirby I, Elliott T, Santis G. The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J Virol 1999;73:4513-4517.
36. Kirby I, Davison E, Beavil AJ, Soh CP, Wickham TJ, Roelvink PW, Kovesdi I, Sutton BJ, Santis G. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J Virol 2000;74:2804-2813.